Hypera S.A. (BVMF:HYPE3)
Brazil · Delayed Price · Currency is BRL 22.14
-0.17 (-0.76%)
At close: Mar 20, 2026
Hypera Revenue
In the year 2025, Hypera had annual revenue of 7.70B BRL with 3.45% growth. Hypera had revenue of 2.24B in the quarter ending December 31, 2025, with 48.05% growth.
Revenue
7.70B
Revenue Growth
+3.45%
P/S Ratio
1.82
Revenue / Employee
728.81K
Employees
10,564
Market Cap
14.01B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 7.70B | 256.69M | 3.45% |
| Dec 31, 2024 | 7.44B | -472.19M | -5.97% |
| Dec 31, 2023 | 7.91B | 368.30M | 4.88% |
| Dec 31, 2022 | 7.55B | 1.61B | 27.10% |
| Dec 31, 2021 | 5.94B | 1.85B | 45.21% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Rede D'Or São Luiz | 55.73B |
| Raia Drogasil | 44.25B |
| Empreendimentos Pague Menos | 14.91B |
| Diagnósticos da América | 12.57B |
| Fleury | 8.29B |
| Oncoclínicas do Brasil Serviços Médicos | 5.94B |
| Dimed S.A. Distribuidora de Medicamentos | 5.29B |
| Odontoprev | 2.53B |
Hypera News
- 9 months ago - Brazil's Hypera announces new majority stakeholder group - Reuters